Cough
📧 Sign up to get email alerts when something new happens for Cough.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-15FDA Approved: DEXTROMETHORPHAN POLISTIREX — Original Application (Aurohealth LLC)
The FDA approved an original-application generic product of dextromethorphan polistirex from Aurohealth LLC.
-
FDA approval · 2026-03-30FDA Approved: BENZONATATE 100 MG — Original Application (MARKSANS PHARMA LIMITED)
FDA approved the original application for BENZONATATE 100 MG (and 200 MG) generic products from Marksans Pharma Limited.
-
EMA approval · 2025-12-08EMA Authorised: Lyfnua (gefapixant) — Merck Sharp & Dohme B.V.
EMA authorised Lyfnua (gefapixant) by Merck Sharp & Dohme B.V. for the treatment of chronic cough.
-
FDA approval · 2025-08-01FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Hydrocodone Bitartrate and Homatropine Methylbromide, an opioid cough suppr…
-
FDA approval · 2025-04-15FDA Approved: RUGBY MUCUS RELIEF ER — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mucus Relief ER (guaifenesin) from Rugby Laboratories, allowing the generic product to be …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-15FDA Approved: PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Promethazine Hydrochloride and Codeine Phosphate from Cosette Pharmaceuticals, indicating an…
-
FDA approval · 2023-07-12FDA Approved: GUAIFENESIN 600 MG — Supplemental Application (Strategic Sourcing Services, LLC)
The FDA approved a supplemental application for Guaifenesin 600 mg from Strategic Sourcing Services, LLC. This action confirms continued app…
-
FDA approval · 2022-12-09FDA Approved: MUCUS RELIEF — Supplemental Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)
FDA approved a supplemental application for MUCUS RELIEF, an over-the-counter guaifenesin product.
-
FDA approval · 2021-09-27FDA Approved: HYCODAN — Supplemental Application (Genus Lifesciences Inc.)
The FDA granted a supplemental approval for HYCODAN, a hydrocodone bitartrate and homatropine methylbromide combination product from Genus L…
-
FDA approval · 2020-10-08FDA Approved: PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approves Promethazine hydrochloride and codeine phosphate as an original application product by Quagen Pharmaceuticals LLC.
-
FDA approval · 2020-09-30FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE — Original Application (BIONPHARMA INC.)
FDA approved Bionpharma's original ANDA for a three-drug cough/cold product containing brompheniramine maleate, pseudoephedrine hydrochlorid…
-
FDA approval · 2020-07-14FDA Approved: BROMPHENIRAMINE, PSEUDOEPHEDRINE, DEXTROMETHORPHAN — Original Application (Ascend Laboratories, LLC)
FDA approves the original ANDA for a triple-ingredient cough/cold product containing brompheniramine, pseudoephedrine, and dextromethorphan …
-
FDA approval · 2020-04-17FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE — Original Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved the original application for a generic combination cough/cold medicine containing brompheniramine maleate, pseudoephedrine hydr…
-
FDA approval · 2020-04-02FDA Approved: MUCINEX — Supplemental Application (RB Health (US) LLC)
The FDA approved a supplemental application for Mucinex (guaifenesin) from RB Health (US) LLC to update/expand the product labeling.
-
FDA approval · 2018-12-19FDA Approved: BENZONATATE — Original Application (Epic Pharma LLC)
FDA approved an original application (ANDA) for benzonatate from Epic Pharma LLC, providing a generic version of the cough suppressant.
-
FDA approval · 2018-07-11FDA Approved: MUCUS RELIEF EXTENDED RELEASE — Original Application (Care One (American Sales Company))
FDA approved the original application for MUCUS RELIEF EXTENDED RELEASE (guaifenesin) from Care One (American Sales Company).
-
FDA approval · 2018-06-28FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Hydrocodone bitartrate and homatropine methylbromide, maintaining its appro…
-
FDA approval · 2018-06-28FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Novel Laboratories, Inc.)
FDA approved a supplemental application for Hydrocodone bitartrate and homatropine methylbromide from Novel Laboratories, Inc.
-
FDA approval · 2018-06-08FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE by Amneal Pharmaceuticals LLC.
-
FDA approval · 2018-03-05FDA Approved: MUCUS DM — Original Application (HyVee Inc)
FDA approved HyVee Inc's MUCUS DM as an original-application generic product containing dextromethorphan hydrobromide and guaifenesin for te…
-
FDA approval · 2017-08-29FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for a generic combination product containing promethazine, phenylephrine, and codeine phosphate manu…
-
FDA approval · 2017-08-07FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Original Application (KVK-Tech, Inc.)
The FDA approved the generic hydrocodone bitartrate and homatropine methylbromide tablet from KVK-Tech, Inc. under an Original Application, …
-
FDA approval · 2017-07-28FDA Approved: DEXTROMETHORPHAN POLISTIREX EXTENDED-RELEASE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's generic dextromethorphan polistirex extended-release for temporary relief of cough due to colds, flu, or other respira…
-
FDA approval · 2017-07-13FDA Approved: MUCINEX DM MAXIMUM STRENGTH — Supplemental Application (RB Health (US) LLC)
FDA approved a supplemental application for Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide) by RB Health (US) LL…
-
FDA approval · 2017-03-17FDA Approved: MUCUS RELIEF DM MAXIMUM STRENGTH — Original Application (Better Living Brands LLC)
The FDA approved the original ANDA for MUCUS RELIEF DM MAXIMUM STRENGTH, a combination product of guaifenesin and dextromethorphan hydrobrom…